Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $48.1 Million - $63.7 Million
537,967 New
537,967 $63.7 Million
Q4 2023

Feb 09, 2024

BUY
$59.53 - $85.11 $21.6 Million - $30.8 Million
362,395 New
362,395 $28.8 Million
Q3 2023

Nov 13, 2024

BUY
$69.23 - $79.09 $23.8 Million - $27.2 Million
344,441 New
344,441 $25.9 Million
Q3 2023

Nov 13, 2023

SELL
$69.23 - $79.09 $29.3 Million - $33.4 Million
-422,661 Closed
0 $0
Q2 2023

Aug 14, 2024

SELL
$45.44 - $71.21 $10.4 Million - $16.3 Million
-229,318 Reduced 42.63%
308,649 $22 Million
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $18.6 Million - $29.2 Million
-410,255 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$43.88 - $52.48 $14.2 Million - $16.9 Million
322,502 New
322,502 $16.2 Million
Q4 2022

Feb 14, 2023

BUY
$40.82 - $57.75 $16.4 Million - $23.3 Million
402,761 New
402,761 $17.6 Million
Q3 2022

Nov 13, 2023

BUY
$46.84 - $58.49 $19.8 Million - $24.7 Million
422,661 New
422,661 $22.5 Million
Q2 2022

Aug 14, 2023

BUY
$34.86 - $63.77 $14.3 Million - $26.2 Million
410,255 New
410,255 $18.6 Million
Q1 2022

May 12, 2023

BUY
$44.33 - $57.82 $1.75 Million - $2.28 Million
39,459 Added 9.8%
442,220 $25.6 Million
Q1 2022

May 09, 2022

SELL
$44.33 - $57.82 $19.6 Million - $25.6 Million
-442,791 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$40.27 - $56.99 $17.8 Million - $25.2 Million
442,791 New
442,791 $19.7 Million
Q3 2021

Nov 14, 2022

BUY
$47.43 - $84.23 $22.4 Million - $39.8 Million
472,036 New
472,036 $22.7 Million
Q3 2021

Nov 05, 2021

SELL
$47.43 - $84.23 $22.4 Million - $39.8 Million
-472,036 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$73.06 - $97.7 $34.5 Million - $46.1 Million
472,036 New
472,036 $40 Million
Q2 2021

Aug 10, 2021

SELL
$73.06 - $97.7 $38.4 Million - $51.3 Million
-525,472 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$70.43 - $97.42 $37 Million - $51.2 Million
525,472 New
525,472 $44.1 Million
Q1 2021

May 07, 2021

SELL
$70.43 - $97.42 $47.8 Million - $66.1 Million
-678,441 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$48.9 - $75.26 $33.2 Million - $51.1 Million
678,441 New
678,441 $51.1 Million
Q4 2020

Feb 10, 2021

SELL
$48.9 - $75.26 $32.2 Million - $49.5 Million
-658,032 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$37.23 - $50.97 $24.5 Million - $33.5 Million
658,032 New
658,032 $32.6 Million
Q3 2020

Nov 10, 2020

SELL
$37.23 - $50.97 $25.5 Million - $34.9 Million
-683,892 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$28.78 - $46.83 $19.7 Million - $32 Million
683,892 New
683,892 $26.3 Million
Q2 2020

Aug 07, 2020

SELL
$28.78 - $46.83 $18.8 Million - $30.5 Million
-652,313 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$25.53 - $70.14 $16.7 Million - $45.8 Million
652,313 New
652,313 $20.1 Million
Q1 2020

May 08, 2020

SELL
$25.53 - $70.14 $16.7 Million - $45.8 Million
-652,313 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$54.18 - $65.64 $35.3 Million - $42.8 Million
652,313 New
652,313 $35.5 Million
Q4 2019

Feb 12, 2020

SELL
$54.18 - $65.64 $35.3 Million - $42.8 Million
-652,313 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$58.58 - $83.91 $38.2 Million - $54.7 Million
652,313 New
652,313 $40.8 Million
Q3 2019

Nov 08, 2019

SELL
$58.58 - $83.91 $39.3 Million - $56.3 Million
-670,737 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$63.59 - $78.71 $42.7 Million - $52.8 Million
670,737 New
670,737 $50.6 Million
Q2 2019

Aug 09, 2019

SELL
$63.59 - $78.71 $21.7 Million - $26.9 Million
-342,009 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$50.75 - $80.54 $14.8 Million - $23.5 Million
292,101 Added 585.28%
342,009 $26.8 Million
Q4 2018

Mar 04, 2019

BUY
$52.18 - $67.93 $2.6 Million - $3.39 Million
49,908 New
49,908 $2.8 Million
Q4 2018

Feb 08, 2019

SELL
$52.18 - $67.93 $2.6 Million - $3.39 Million
-49,908 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$38.13 - $68.37 $1.9 Million - $3.41 Million
49,908 New
49,908 $3.24 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.